Literature DB >> 2155857

DNA methylation in Neisseria gonorrhoeae and other Neisseriae.

N Ritchot1, P H Roy.   

Abstract

It has been reported in the literature that Neisseria gonorrhoeae DNA is modified by the methyltransferases (MTases) M.NgoI, M.NgoII, and M.NgoIII, as well as three other cytosine MTases and one adenine MTase, even if the corresponding restriction endonucleases are not present. We envisioned the possibility of cloning one of the N. gonorrhoeae MTase-encoding genes for use as a species-specific DNA probe. We therefore undertook a survey of methylation patterns of several clinical isolates of N. gonorrhoeae and N. meningitidis as well as ATCC strains of other Neisseriae. We found, from digestion patterns with isoschizomers, one N. gonorrhoeae strain that lacked M.NgoII and two that lacked M.NgoIII. All N. meningitidis strains (save one) were resistant to digestion with NlaIV thus possessing an MTase like NgoV, and one was resistant to SstII, thus having an NgoIII-like MTase. None were resistant to isoschizomers of NgoI, NgoIII and NgoIV. Some other Neisseriae had an MTase with NlaIV (NgoV) specificity, but none had NgoI, II, III or IV specificity, except for the Branhamella-like N. caviae-ovis group and N. lactamica where these specificities were present in at least one strain of this group. Therefore, among the Neisseriae other than N. caviae only M.NgoI is N. gonorrhoeae-specific.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155857     DOI: 10.1016/0378-1119(90)90120-g

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Effect of site-specific methylation on DNA modification methyltransferases and restriction endonucleases.

Authors:  M McClelland; M Nelson
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  Site-specific methylation: effect on DNA modification methyltransferases and restriction endonucleases.

Authors:  M Nelson; M McClelland
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

3.  Differential distribution of novel restriction-modification systems in clonal lineages of Neisseria meningitidis.

Authors:  H Claus; A Friedrich; M Frosch; U Vogel
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

4.  Identification of type II restriction and modification systems in Helicobacter pylori reveals their substantial diversity among strains.

Authors:  Q Xu; R D Morgan; R J Roberts; M J Blaser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

5.  The NlaIV restriction and modification genes of Neisseria lactamica are flanked by leucine biosynthesis genes.

Authors:  P C Lau; F Forghani; D Labbé; H Bergeron; R Brousseau; H J Höltke
Journal:  Mol Gen Genet       Date:  1994-04

6.  Restriction and sequence alterations affect DNA uptake sequence-dependent transformation in Neisseria meningitidis.

Authors:  Ole Herman Ambur; Stephan A Frye; Mariann Nilsen; Eirik Hovland; Tone Tønjum
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

7.  A method for selectively enriching microbial DNA from contaminating vertebrate host DNA.

Authors:  George R Feehery; Erbay Yigit; Samuel O Oyola; Bradley W Langhorst; Victor T Schmidt; Fiona J Stewart; Eileen T Dimalanta; Linda A Amaral-Zettler; Theodore Davis; Michael A Quail; Sriharsa Pradhan
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

8.  DNA Methylation Assessed by SMRT Sequencing Is Linked to Mutations in Neisseria meningitidis Isolates.

Authors:  Mohamad R Abdul Sater; Araceli Lamelas; Guilin Wang; Tyson A Clark; Katharina Röltgen; Shrikant Mane; Jonas Korlach; Gerd Pluschke; Christoph D Schmid
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

9.  Dam inactivation in Neisseria meningitidis: prevalence among diverse hyperinvasive lineages.

Authors:  Keith A Jolley; Li Sun; E Richard Moxon; Martin C J Maiden
Journal:  BMC Microbiol       Date:  2004-08-31       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.